Except that the EU isn't getting the doses it ordered, and the shortfall is significant, and it has actually exported a significant chunk.
Whereas the UK is getting the doses it ordered, at the EU's expense, and has not actually exported any.
So.
Not exactly the same.
The U.K. is also experiencing a significant shortfall in doses compared to those that were projected to be delivered by AZ. Production yields have been lower across the board according to Oxford researchers involved in the scale up, and several delivery milestones were missed for the U.K.